Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4551–4600 of 75371
On January 30, 2025, Janet Liang submitted to the Lincoln National Corporation (the "Company") Board of Directors (the "Board") her resignation from her position as a director on the Board, with such resignation to be effective immediately.
who by mutual agreement with the Board has resigned his positions as Chief Executive Officer and a director of the Company, effective on the Effective Date.
On January 29, 2025, Katherine Doyle, an independent member of the Perrigo Company plc (the “Company”) Board of Directors, advised Perrigo’s Nominating & Governance Committee that she will not stand for re-election to our Board of Directors at the Company’s annual general meeting of shareholders in 2025 and intends to retire from our Board at that time.
Marc DeBevoise, Diane Hessan, Kristin Frank, Gary Haroian, Scott Kurnit, Tsedal Neeley, and Thomas E. Wheeler each resigned from the board of directors of the Company
Marc DeBevoise, Diane Hessan, Kristin Frank, Gary Haroian, Scott Kurnit, Tsedal Neeley, and Thomas E. Wheeler each resigned from the board of directors of the Company
Marc DeBevoise, Diane Hessan, Kristin Frank, Gary Haroian, Scott Kurnit, Tsedal Neeley, and Thomas E. Wheeler each resigned from the board of directors of the Company
Marc DeBevoise, Diane Hessan, Kristin Frank, Gary Haroian, Scott Kurnit, Tsedal Neeley, and Thomas E. Wheeler each resigned from the board of directors of the Company
Marc DeBevoise, Diane Hessan, Kristin Frank, Gary Haroian, Scott Kurnit, Tsedal Neeley, and Thomas E. Wheeler each resigned from the board of directors of the Company
Marc DeBevoise, Diane Hessan, Kristin Frank, Gary Haroian, Scott Kurnit, Tsedal Neeley, and Thomas E. Wheeler each resigned from the board of directors of the Company
Marc DeBevoise, Diane Hessan, Kristin Frank, Gary Haroian, Scott Kurnit, Tsedal Neeley, and Thomas E. Wheeler each resigned from the board of directors of the Company
On January 30, 2025, C. Kim Goodwin informed the Company that she has decided not to stand for reelection to the Board of Directors at the Company’s 2025 Annual Meeting of Shareholders in September.
Eduardo F. Menezes will succeed Seifollah (“Seifi”) Ghasemi as the Company’s Chief Executive Officer effective February 7, 2025.
On January 30, 2025, the Company and Mr. Bush entered into a Separation and Release of Claims Agreement (the “Separation Agreement”), pursuant to which Mr. Bush is entitled to receive the following payments and benefits in accordance with the existing terms of his employment agreement with the Company:
Effective February 1, 2025, Joseph Moscovitz retired as a director of Actelis Networks, Inc.
On December 21, 2024, Barry M. Edelstein, a member of the Company’s Board of Directors (“Board”), notified the Company of his intention to resign from the Board due to changing professional priorities, effective December 31, 2024.
On February 3, 2025, Michael Ellis, the General Counsel and Corporate Secretary of Rumble Inc. (the “Company”), has informed the Company of his resignation from his position effective February 7, 2025, to pursue a position in government.
By eliminating the position of COO, the Board also terminated the employment of Randall A. Meyer, effective immediately;
On January 20, 2025, Gert Funk resigned from the board of directors of RocketFuel Blockchain, Inc.
On January 30, 2025, Mr. Darren Williams, a member of the Board of Directors (the “Board”) of Daybreak Oil and Gas, Inc. (the “Company”) notified the Company’s President and Chief Executive Officer of his resignation from his board position, effective as of January 30, 2025.
Steven Wolin resigned as EVP and Chief Operating Officer of the Company, effective as of February 5, 2025.
Alessandrea Quane, the Company’s EVP, Chief Insurance Officer, will cease serving in this role effective as of February 24, 2025 and her employment with the Company and Oscar Management Corporation (“OMC”) will terminate effective as of March 3, 2025.
On February 3, 2025, M. Bridget Duffy, MD resigned from the Board.
Mark Williams voluntarily resigned from his position as a member of the Company's Board of Directors and from all of its committees, effective immediately.
On February 3, 2025, Mr. Jaydriane (Jay) Panis, a member of the Board of Directors (the “Board”) of Virpax Pharmaceuticals, Inc. (the “Company”), notified the Board of his resignation from the Board and the Board’s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, effective immediately.
On January 28, 2025, Guoxiang Yang resigned from his position as the Company's Chief Financial Officer.
On January 28, 2025, Zonghan Wu resigned from his position as the Company's Chief Executive Officer.
On January 30, 2025, Richard Galanti retired as Executive Vice President of the Company.
On February 3, 2025, SSR Mining Inc., a British Columbia corporation (the “Company”), announced that Ms. Leigh Ann Fisher has made the decision to resign from the Board of Directors of the Company (the “Board”) effective as of January 30, 2025 for personal reasons.
Effective on January 31, 2025, Deon Riley ceased to serve as Chief Human Resources Officer of Bath & Body Works, Inc.
each of Michael S. Dell, William Cary, Pamela Daley, Mark J. Hawkins, Kyle Paster, Wendy Thomas and Yagyensh C. Pati resigned from his or her respective position as a member of the Company’s Board of Directors, and any committee thereof
each of Michael S. Dell, William Cary, Pamela Daley, Mark J. Hawkins, Kyle Paster, Wendy Thomas and Yagyensh C. Pati resigned from his or her respective position as a member of the Company’s Board of Directors, and any committee thereof
each of Michael S. Dell, William Cary, Pamela Daley, Mark J. Hawkins, Kyle Paster, Wendy Thomas and Yagyensh C. Pati resigned from his or her respective position as a member of the Company’s Board of Directors, and any committee thereof
each of Michael S. Dell, William Cary, Pamela Daley, Mark J. Hawkins, Kyle Paster, Wendy Thomas and Yagyensh C. Pati resigned from his or her respective position as a member of the Company’s Board of Directors, and any committee thereof
each of Michael S. Dell, William Cary, Pamela Daley, Mark J. Hawkins, Kyle Paster, Wendy Thomas and Yagyensh C. Pati resigned from his or her respective position as a member of the Company’s Board of Directors, and any committee thereof
each of Michael S. Dell, William Cary, Pamela Daley, Mark J. Hawkins, Kyle Paster, Wendy Thomas and Yagyensh C. Pati resigned from his or her respective position as a member of the Company’s Board of Directors, and any committee thereof
each of Michael S. Dell, William Cary, Pamela Daley, Mark J. Hawkins, Kyle Paster, Wendy Thomas and Yagyensh C. Pati resigned from his or her respective position as a member of the Company’s Board of Directors, and any committee thereof
On January 30, 2025, Thomas A. West notified Inogen, Inc. (“the Company”) of his resignation as a member of the Board of Directors (the “Board”) of the Company, the Compliance Committee of the Board (the “Compliance Committee”), and the Nominating and Governance Committee of the Board (the “Nominating and Governance Committee”), in each case effective as of January 30, 2025.
Scott Braunstein, M.D. resigned from the Board of Directors of the Company (the “Board”) and the Audit Committee thereof, effective as of January 31, 2025.
Thomas Klaritch, currently the Company’s Chief Operating Officer, will retire from the Company.
On January 30, 2025, Chonda J. Nwamu, Executive Vice President, General Counsel and Secretary of Ameren Corporation (the “Company”) informed the Company of her intent to resign from her roles with the Company and its subsidiaries, effective March 10, 2025.
John T. Jimenez, who has served as Chief Financial Officer of the Company since 2021, intends to retire from the Company
Gregory J. Hayes, RTX’s current Executive Chairman, has informed the Board of Directors of his intention to not stand for re-election and to step down as Executive Chairman and as a member of the Board, effective April 30, 2025.
the following individuals, each of whom was a member of the board of directors of HTLF immediately prior to the Effective Time, were appointed to the board of directors of UMB: John Schmidt, Brad Henderson, Jennifer Hopkins, Margaret Lazo and Susan Murphy.
the following individuals, each of whom was a member of the board of directors of HTLF immediately prior to the Effective Time, were appointed to the board of directors of UMB: John Schmidt, Brad Henderson, Jennifer Hopkins, Margaret Lazo and Susan Murphy.
the following individuals, each of whom was a member of the board of directors of HTLF immediately prior to the Effective Time, were appointed to the board of directors of UMB: John Schmidt, Brad Henderson, Jennifer Hopkins, Margaret Lazo and Susan Murphy.
the following individuals, each of whom was a member of the board of directors of HTLF immediately prior to the Effective Time, were appointed to the board of directors of UMB: John Schmidt, Brad Henderson, Jennifer Hopkins, Margaret Lazo and Susan Murphy.
the following individuals, each of whom was a member of the board of directors of HTLF immediately prior to the Effective Time, were appointed to the board of directors of UMB: John Schmidt, Brad Henderson, Jennifer Hopkins, Margaret Lazo and Susan Murphy.
On January 30, 2025, Jeffrey Landau, Senior Vice President, Chief Business Officer, and Head of Strategy, of CytomX Therapeutics, Inc. (the “Company”) and the Company agreed that Mr. Landau’s employment by the Company would terminate, effective February 7, 2025.
the date that Wissam G. Jabre will cease to be the Company’s Chief Financial Officer
On January 30, 2025, Reuben Jeffery III notified Affiliated Managers Group, Inc. (“AMG”) of his decision to retire from the Board of Directors (the “Board”), effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.